[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE602004004677D1 - Verfahren zur herstellung substituierter 5-amino-pyrazolo-ä4,3-eü-1,2,4-triazoloä1,5-cüpyrimidine - Google Patents

Verfahren zur herstellung substituierter 5-amino-pyrazolo-ä4,3-eü-1,2,4-triazoloä1,5-cüpyrimidine

Info

Publication number
DE602004004677D1
DE602004004677D1 DE602004004677T DE602004004677T DE602004004677D1 DE 602004004677 D1 DE602004004677 D1 DE 602004004677D1 DE 602004004677 T DE602004004677 T DE 602004004677T DE 602004004677 T DE602004004677 T DE 602004004677T DE 602004004677 D1 DE602004004677 D1 DE 602004004677D1
Authority
DE
Germany
Prior art keywords
cüpyrimidine
pyrazolo
amino
preparing substituted
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004004677T
Other languages
English (en)
Other versions
DE602004004677T2 (de
Inventor
Shen-Chun Kuo
Jieh-Shyh Tsai
Thanh Tran
Pengyi Zhang
D Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of DE602004004677D1 publication Critical patent/DE602004004677D1/de
Application granted granted Critical
Publication of DE602004004677T2 publication Critical patent/DE602004004677T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE602004004677T 2003-10-28 2004-10-26 Verfahren zur Herstellung substituierter 5-Amino-Pyrazolo-(4,3-E)-1,2,4-Triazo lo (1,5-C)Pyrimidine Expired - Lifetime DE602004004677T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51505103P 2003-10-28 2003-10-28
US515051P 2003-10-28
PCT/US2004/035472 WO2005044819A1 (en) 2003-10-28 2004-10-26 Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines

Publications (2)

Publication Number Publication Date
DE602004004677D1 true DE602004004677D1 (de) 2007-03-22
DE602004004677T2 DE602004004677T2 (de) 2007-11-15

Family

ID=34572798

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004004677T Expired - Lifetime DE602004004677T2 (de) 2003-10-28 2004-10-26 Verfahren zur Herstellung substituierter 5-Amino-Pyrazolo-(4,3-E)-1,2,4-Triazo lo (1,5-C)Pyrimidine

Country Status (19)

Country Link
US (4) US7223861B2 (de)
EP (1) EP1678182B1 (de)
JP (2) JP4782693B2 (de)
CN (2) CN101899050A (de)
AR (1) AR046560A1 (de)
AT (1) ATE353331T1 (de)
CA (1) CA2543431A1 (de)
CY (1) CY1106393T1 (de)
DE (1) DE602004004677T2 (de)
DK (1) DK1678182T3 (de)
ES (1) ES2278353T3 (de)
HK (1) HK1086008A1 (de)
HR (1) HRP20070063T3 (de)
MX (1) MXPA06004722A (de)
PL (1) PL1678182T3 (de)
PT (1) PT1678182E (de)
SI (1) SI1678182T1 (de)
WO (1) WO2005044819A1 (de)
ZA (1) ZA200603307B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI288137B (en) * 2000-05-26 2007-10-11 Schering Corp Adenosine A2a receptor antagonists
DE602004004677T2 (de) * 2003-10-28 2007-11-15 Schering Corp. Verfahren zur Herstellung substituierter 5-Amino-Pyrazolo-(4,3-E)-1,2,4-Triazo lo (1,5-C)Pyrimidine
ATE556712T1 (de) * 2005-06-07 2012-05-15 Kyowa Hakko Kirin Co Ltd A2a antagonisten zur behandlung von motorischen störungen
US8598343B2 (en) * 2009-08-07 2013-12-03 Merck Sharp & Dohme Corp. Process for preparing a 2-alkynyl substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine
US20110144049A1 (en) * 2009-10-21 2011-06-16 Serebruany Victor L Treating Cardiac Arrhythmias, Heart Failure, Peripheral Artery Disease and Stroke with Cyclopentyl-Triazolo-Pyrimidine or Derivative Thereof
WO2013024474A1 (en) * 2011-08-18 2013-02-21 Mapi Phrarma Ltd. Polymorphs of preladenant
JPWO2013168196A1 (ja) 2012-05-10 2015-12-24 ユニテクノ株式会社 半導体搬送テスト治具
AR102088A1 (es) * 2014-09-26 2017-02-01 Genentech Inc Procesos para preparar compuestos de (ciclopentil[d]pirimidin-4-il)piperazina
WO2020112700A1 (en) 2018-11-30 2020-06-04 Merck Sharp & Dohme Corp. 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4039733A1 (de) * 1990-12-13 1992-06-17 Basf Ag Substituierte 5-aminopyrazole
IT1264901B1 (it) * 1993-06-29 1996-10-17 Schering Plough S P A Analoghi eterociclici di 1,2,4-triazolo(15-c)pirimidine ad attivita' antagonista per il recettore a2 dell'adenosina
US6448253B1 (en) 1998-09-16 2002-09-10 King Pharmaceuticals Research And Development, Inc. Adenosine A3 receptor modulators
TWI288137B (en) 2000-05-26 2007-10-11 Schering Corp Adenosine A2a receptor antagonists
CN1491227A (zh) * 2001-02-05 2004-04-21 株式会社大V制药工厂 三唑并喹唑啉和吡唑并三唑并嘧啶衍生物、医药组合物、腺苷 a 3受体亲和剂、降眼压剂、预防和治疗青光眼的制剂及降低眼压的方法
US7179801B2 (en) * 2001-05-01 2007-02-20 Astellas Pharma Inc. Cephem compounds
ES2336435T3 (es) * 2001-11-30 2010-04-13 Schering Corporation Antagonista del receptor de adenosina a2a.
DE602004004677T2 (de) * 2003-10-28 2007-11-15 Schering Corp. Verfahren zur Herstellung substituierter 5-Amino-Pyrazolo-(4,3-E)-1,2,4-Triazo lo (1,5-C)Pyrimidine
ATE377599T1 (de) * 2003-12-01 2007-11-15 Schering Corp Verfahren zur herstellung von substituierten 5- aminopyrazolo(4,3-e)-1,2,4-triazolo(1,5- c)pyrimidinen

Also Published As

Publication number Publication date
SI1678182T1 (sl) 2007-06-30
ZA200603307B (en) 2008-07-30
US7439361B2 (en) 2008-10-21
PL1678182T3 (pl) 2007-05-31
JP4782693B2 (ja) 2011-09-28
US7601833B2 (en) 2009-10-13
MXPA06004722A (es) 2006-07-05
DK1678182T3 (da) 2007-06-04
HK1086008A1 (en) 2006-09-08
CY1106393T1 (el) 2011-10-12
US20070203340A1 (en) 2007-08-30
CN1898246A (zh) 2007-01-17
US20050090492A1 (en) 2005-04-28
EP1678182A1 (de) 2006-07-12
EP1678182B1 (de) 2007-02-07
PT1678182E (pt) 2007-04-30
US7223861B2 (en) 2007-05-29
DE602004004677T2 (de) 2007-11-15
JP2011116795A (ja) 2011-06-16
JP2007509948A (ja) 2007-04-19
AR046560A1 (es) 2005-12-14
CN101899050A (zh) 2010-12-01
CA2543431A1 (en) 2005-05-19
US20090005559A1 (en) 2009-01-01
US20090326241A1 (en) 2009-12-31
CN1898246B (zh) 2010-10-27
ES2278353T3 (es) 2007-08-01
ATE353331T1 (de) 2007-02-15
HRP20070063T3 (en) 2007-04-30
WO2005044819A1 (en) 2005-05-19

Similar Documents

Publication Publication Date Title
DE502004009768D1 (de) Verfahren zur herstellung von dreiwertigen organophosphor-verbindungen
DE502004009763D1 (de) Verfahren zur herstellung von 1-buten
DE50307672D1 (de) Verfahren zur herstellung von polycarbonaten
ATE502058T1 (de) Verfahren zur herstellung von 1,2-dichlorethan
DE60234952D1 (de) VERFAHREN ZUR HERSTELLUNG VON HEXAHYDROFUROc2,3-BÜFURAN-3-OL
DE60112305D1 (de) Verfahren zur herstellung amlodipinmaleat
DE60317690D1 (de) Verfahren zur herstellung von valsartan
ATE414077T1 (de) Verfahren zur herstellung von 1-ä(benzimidazol-1- yl)chinolin-8-ylüpiperidin-4-ylaminderivaten
DE502005010038D1 (de) Verfahren zur herstellung von 3-pentennitril
DE60302139D1 (de) Verfahren zur herstellung von aripiprazole
DE502005001841D1 (de) Verfahren zur herstellung von 1,4-diphenylazetidinon-derivaten
ATE506351T1 (de) Verfahren zur herstellung von 10,11-dihydro-10- oxo-5h-dibenzoäb,füazepin-5-carboxamid
DE502004005985D1 (de) Verfahren zur herstellung von carbonylreste-aufweisenden organosiliciumverbindungen
DE502005000428D1 (de) Verfahren zur Herstellung von 1,2-Diaminocyclohexan-Platin(II)-Komplexen
DE602004004677D1 (de) Verfahren zur herstellung substituierter 5-amino-pyrazolo-ä4,3-eü-1,2,4-triazoloä1,5-cüpyrimidine
DE60336822D1 (de) Verfahren zur herstellung von kristallinem 1,2-polybutadien
DE602005021110D1 (de) Verfahren zur herstellung von n-piperidino-1,5-diphenylpyrazol-3-carboxamid-derivaten
DE60226310D1 (de) Verfahren zur herstellung von cycloolefinadditionspolymerisat
DE602005011814D1 (de) Verfahren zur herstellung von enantiomerreinen 1,1'-spirobiindan-6,6'-diol-derivaten
DE502005007702D1 (de) Verfahren zur herstellung von terrylen-3,4:11,12-t
DE602005014280D1 (de) Verfahren zur herstellung von ä1,4,5ü-oxadiazepinderivaten
DE502004002810D1 (de) Verfahren zur herstellung von copolymerisaten
DE602004005239D1 (de) Verfahren zur herstellung von tubulininhibitoren
DE602004027840D1 (de) Verfahren zur herstellung von thiazolopyrimidinen
DE602004030571D1 (de) Verfahren zur herstellung optisch aktiven 1-alkyl-substituierter 2,2,2-trifluorethylamins

Legal Events

Date Code Title Description
8364 No opposition during term of opposition